Burke-Hocoma Efficiency Study

Hemiplegia Clinical Trial

Official title: Burke-Hocoma Efficiency Study

Status Completed

Clinical Trial Summary

The ArmeoSpring device is an exoskeleton (3 joints and 6 degrees of freedom) with integrated springs. The investigators hypothesize that 3 days of training for 6 weeks with the Hocoma Armeo Spring device will be efficient and more effective than one on one ArmeoSpring therapy.

Clinical Trial Description

In the proposed study, 20 stable subacute and chronic stroke patients will be placed in two groups: 2:1 treatment for 3 weeks (2 patients on 2 robots with one therapist; 60 minutes on robot) then 1 on 1 intervention with the therapist (60 minutes of Hocoma Armeo Spring robotic training) or visa versa. Patients will be assessed using robotic kinematics and standardized occupational therapy motor assessments. The extreme precision afforded by robotic physical rehabilitation therapies makes them an appealing and growing field in rehabilitation.

Determining efficiency of new technologies, while maintaining the highest quality of care, is of priority in the medical field at this time. Devices such as the ArmeoSpring could lead to reduced disability, thereby increasing function and improving quality of life in patients experiencing neurological illness or injury. The ArmeoSpring has potential to decrease cost for both the provider and patient over time while providing more engaging, evidence-based therapy. ;

Related Conditions & MeSH terms

• Hemiparesis
• Hemiplegia
• Paresis

• NCT number: NCT03555825
• Study type: Interventional
• Source: Burke Medical Research Institute
• Status: Completed
• Phase: Phase 3
• Start date: May 1, 2016
• Completion date: December 2020